State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Lung & Bronchus (Late Stage^), 2018-2022

All Races (includes Hispanic), Female, All Ages

Sorted by Percentlate

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 30.0 with a 95% confidence interval from 29.9 to 30.1 and 68,578 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Puerto Rico²

• Rate : The incidence rate is 5.0 with a 95% confidence interval from 4.6 to 5.4 and 141 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 31.3 with a 95% confidence interval from 30.6 to 32.0 and 1,588 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (19, 29)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 29.2 with a 95% confidence interval from 28.5 to 30.0 and 1,125 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (28, 37)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 32.3 with a 95% confidence interval from 30.5 to 34.1 and 266 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (14, 31)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 24.1 with a 95% confidence interval from 23.1 to 25.1 and 490 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (42, 46)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 22.3 with a 95% confidence interval from 21.7 to 22.9 and 1,158 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (45, 49)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 27.4 with a 95% confidence interval from 26.7 to 28.2 and 1,009 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (34, 42)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 27.8 with a 95% confidence interval from 26.5 to 29.2 and 356 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (30, 42)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 30.7 with a 95% confidence interval from 29.8 to 31.7 and 830 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (21, 32)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 17.5 with a 95% confidence interval from 16.5 to 18.5 and 269 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (50, 50)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 24.9 with a 95% confidence interval from 22.6 to 27.3 and 94 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (36, 48)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 29.6 with a 95% confidence interval from 29.1 to 30.0 and 4,273 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (29, 34)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 21.5 with a 95% confidence interval from 20.8 to 22.2 and 758 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (46, 49)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 36.2 with a 95% confidence interval from 35.0 to 37.4 and 771 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (6, 16)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 30.5 with a 95% confidence interval from 28.3 to 32.8 and 156 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (17, 39)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 26.8 with a 95% confidence interval from 25.2 to 28.5 and 218 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (32, 44)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 27.1 with a 95% confidence interval from 26.2 to 27.9 and 829 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (35, 42)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 30.3 with a 95% confidence interval from 29.9 to 30.6 and 5,399 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (25, 31)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 34.7 with a 95% confidence interval from 33.1 to 36.4 and 371 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (6, 21)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 32.2 with a 95% confidence interval from 31.7 to 32.7 and 3,217 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (17, 25)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 28.1 with a 95% confidence interval from 27.5 to 28.8 and 1,644 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (32, 40)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 31.8 with a 95% confidence interval from 29.8 to 34.0 and 192 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (14, 34)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 31.7 with a 95% confidence interval from 29.5 to 34.2 and 151 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (13, 36)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 28.6 with a 95% confidence interval from 28.0 to 29.3 and 1,430 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (30, 38)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 28.6 with a 95% confidence interval from 27.9 to 29.3 and 1,233 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (30, 39)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 35.9 with a 95% confidence interval from 35.4 to 36.5 and 3,075 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (6, 14)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 23.8 with a 95% confidence interval from 21.6 to 26.1 and 92 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (38, 49)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 33.2 with a 95% confidence interval from 31.4 to 35.1 and 264 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (10, 28)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 29.0 with a 95% confidence interval from 28.4 to 29.6 and 1,913 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (30, 37)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 31.1 with a 95% confidence interval from 30.3 to 31.9 and 1,207 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (19, 30)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 24.5 with a 95% confidence interval from 24.1 to 24.8 and 4,016 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (42, 46)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 37.0 with a 95% confidence interval from 36.2 to 37.8 and 1,794 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (5, 10)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 32.5 with a 95% confidence interval from 31.7 to 33.3 and 1,371 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (17, 25)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 39.8 with a 95% confidence interval from 38.1 to 41.5 and 458 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (3, 6)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 31.3 with a 95% confidence interval from 30.2 to 32.5 and 613 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (17, 30)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 35.1 with a 95% confidence interval from 34.4 to 35.7 and 2,589 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (9, 17)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 39.4 with a 95% confidence interval from 38.6 to 40.3 and 1,740 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (3, 5)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 21.5 with a 95% confidence interval from 21.2 to 21.8 and 5,293 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (47, 49)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 36.5 with a 95% confidence interval from 35.5 to 37.6 and 962 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (6, 14)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 34.4 with a 95% confidence interval from 33.8 to 35.0 and 3,011 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (13, 18)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 35.5 with a 95% confidence interval from 34.3 to 36.7 and 736 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (6, 17)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 46.3 with a 95% confidence interval from 44.7 to 48.0 and 654 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (2, 2)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 35.4 with a 95% confidence interval from 34.8 to 36.1 and 2,614 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (7, 16)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 32.6 with a 95% confidence interval from 29.9 to 35.4 and 123 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (8, 34)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 27.0 with a 95% confidence interval from 25.7 to 28.4 and 320 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (33, 43)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 30.8 with a 95% confidence interval from 30.2 to 31.4 and 2,108 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (21, 30)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 38.7 with a 95% confidence interval from 37.9 to 39.6 and 1,774 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (3, 6)
• Percent of Cases with Late Stage :

Utah⁷

• Rate : The incidence rate is 15.2 with a 95% confidence interval from 14.3 to 16.1 and 236 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (51, 51)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 36.3 with a 95% confidence interval from 35.2 to 37.5 and 814 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (6, 15)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 50.0 with a 95% confidence interval from 48.9 to 51.1 and 1,589 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 1)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 35.4 with a 95% confidence interval from 34.4 to 36.3 and 1,118 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (7, 17)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 24.1 with a 95% confidence interval from 22.8 to 25.5 and 265 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (41, 47)
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/22/2026 9:20 pm.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.